Roche Hldgs (GENUS) Dividend yield

Roche Hldgs (GENUS) is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Roche Hldgs (GENUS) is a company from Switzerland, and his stocks are publicly traded.

Roche Hldgs (GENUS) stock dividend

Roche Hldgs (GENUS) paid a total dividend of 6,584 million CHF last year, for a market value of 180,388 millions (Market Cap 180,255 millions). Roche Hldgs (GENUS) dividend per share is 9.50 CHF, and his stock market price 260.30 CHF.

According to the chart below, where dividend yield is displayed, Roche Hldgs (GENUS) has a dividend yield of 3.65%, which is higher than the amount offered by both the market average and companies from Switzerland. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare Roche Hldgs (GENUS) stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the best Switzerland dividend stocks list.

Roche Hldgs (GENUS) Dividend Payout

About the ability of Roche Hldgs (GENUS) to maintain his current dividend of CHF 9.50 per share, an amount that accounts for 3.65%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Roche Hldgs (GENUS) payout on ernings is currently 60.59%, which is higher than the market average, and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that Roche Hldgs (GENUS) can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Roche Hldgs (GENUS) is CHF 20.99 per share, which is higher than the dividend per share paid by the company of CHF 9.50, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Roche Hldgs (GENUS), compared againt world market average, Switzerland companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Roche Hldgs (GENUS) Dividend History

Below you will find a table with the historical evolution of Roche Hldgs (GENUS)'s dividend stock, both in percentage and in CHF, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	CHF	Paypout	Shares*
Present	3.65%	9.50	60.59%	693
2022	3.20%	9.30	51.21%	694
2021	2.40%	9.10	48.48%	693
2020	2.91%	8.99	51.20%	696
2019	2.77%	8.70	63.18%	694
2018	3.41%	8.30	68.54%	694
2017	3.33%	8.21	61.64%	693
2016	3.57%	8.09	66.37%	703
2015	2.90%	7.99	69.00%	703

*In millions

Then you can see the evolution of Roche Hldgs (GENUS) dividend stock, and compare it with the average of Switzerland stocks and that of the Pharmaceuticals and Biotechnology stocks.

Roche Hldgs (GENUS) Stock performance

Finally, last moth Roche Hldgs (GENUS) showed a return of -3.80% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -17.50% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for Switzerland and Pharmaceuticals and Biotechnology firms.